Zepbound

Zepbound came off the FDA shortage list in December 2024, but the higher maintenance doses still hit periodic supply gaps in 2026.

Yes, Zepbound often causes increased urination, especially in the first few weeks.

The short version: Zepbound does not give you energy in the way a stimulant or thyroid pill does.

Introduction The honest answer is that no human data shows Zepbound® causes cancer, but the FDA boxed warning for thyroid C-cell tumors exists because…

Cigna runs pharmacy benefits through Express Scripts, which means Zepbound denials come back as Express Scripts adverse determination letters.

Yes, in most cases. Ibuprofen and Zepbound (tirzepatide) do not have a known pharmacokinetic interaction.

Introduction Zepbound® is officially off the FDA shortage list, but pharmacy-level supply gaps at the 12.5 mg and 15 mg maintenance doses still hit…

Introduction Blue Cross Blue Shield denies Zepbound® through one of five patterns: PA criteria not met, non-formulary on the plan, step therapy requirement (commonly…

Anthem owns 14 Blue Cross Blue Shield licensees and processes pharmacy benefits through CarelonRx (formerly IngenioRx), Anthem’s wholly-owned PBM.